Physician profile
Cuong Q Bui
NPI 1750574992
$8,230.88
in general payments reported to CMS, 2019-2025
18 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $298 · 2021: $581 · 2022: $3,618 · 2023: $1,753 · 2024: $1,304 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881 · Travel and Lodging: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.52 |
| Travel and Lodging | $1,379.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $3,285.18 | 2022-2024 | Image Guided Surgical Device, Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Spine Wave, INC. | $1,517.59 | 2019-2025 | Spinal Implant |
| Globus Medical, INC. | $1,215.72 | 2022-2025 | Excelsiusgps Robotic Navigation System, Coalition, Excelsius Gps |
| Medtronic, INC. | $595.60 | 2021-2023 | Mazor X System, Synchromedii |
| Stryker Corporation | $379.88 | 2023 | Everest Spinal System |
| Boston Scientific Corporation | $324.14 | 2019-2023 | |
| Providence Medical Technology, INC. | $205.97 | 2022-2023 | |
| Relievant Medsystems, INC. | $132.01 | 2023 | Intracept |
| Isoray, INC | $128.07 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $127.79 | 2021 | |
| Depuy Synthes Sales INC. | $84.01 | 2021-2025 | |
| Integra Lifesciences Corporation | $81.56 | 2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Livanova USA, INC. | $55.80 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Aesculap, INC. | $30.88 | 2019 | |
| Acadia Pharmaceuticals INC | $20.47 | 2023 | Nuplazid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $19.36 | 2023 | Rexulti |
| Medtronic USA, INC. | $14.85 | 2020 | |
| Omniscient Neurotechnology America Ltd | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cuong Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.